Let me just explain. The government support goes mostly into basic research and the academic environment, which is very important because that's the watering hole for discovery. We then have to translate that discovery and make it investable. In other words, we have to validate the data that comes out of that. We have to add value and get proof of concept. We do it as far as animal studies are concerned. We sometimes take it into the clinic, but we need investment and partnership to do that.
In drug development that life cycle is a 10- or 15-year life cycle, $1 billion to $1.5 billion, so partnership is everything. We have to be partnered and de-risked. People will only invest where there's an ability to protect the IP, where there's an environment where these technologies can be nurtured.